87 related articles for article (PubMed ID: 11227494)
21. Cell cycle kinetics of aerated, hypoxic and re-aerated cells in vitro using flow cytometric determination of cellular DNA and incorporated bromodeoxyuridine.
Shrieve DC; Begg AC
Cell Tissue Kinet; 1985 Nov; 18(6):641-51. PubMed ID: 4064107
[TBL] [Abstract][Full Text] [Related]
22. Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis.
Léonce S; Pérez V; Lambel S; Peyroulan D; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman JA; Pierré A
Mol Pharmacol; 2001 Dec; 60(6):1383-91. PubMed ID: 11723246
[TBL] [Abstract][Full Text] [Related]
23. Chitooligosaccharides promote radiosensitivity in colon cancer line SW480.
Han FS; Yang SJ; Lin MB; Chen YQ; Yang P; Xu JM
World J Gastroenterol; 2016 Jun; 22(22):5193-200. PubMed ID: 27298562
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on radiation induction of DNA and chromosome damage and its correlation with cell killing.
Iliakis G; Kurtzman S; Pantelias G; Okayasu R
Radiat Res; 1989 Aug; 119(2):286-304. PubMed ID: 2756119
[TBL] [Abstract][Full Text] [Related]
25. Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002).
Nishimura Y; Nakagawa K; Takeda K; Tanaka M; Segawa Y; Tsujino K; Negoro S; Fuwa N; Hida T; Kawahara M; Katakami N; Hirokawa K; Yamamoto N; Fukuoka M; Ariyoshi Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):786-92. PubMed ID: 17512126
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on cell killing and interphase chromosome breakage in radiation-sensitive cells.
Iliakis G; Pantelias G; Kurtzman S
Radiat Res; 1991 Jan; 125(1):56-64. PubMed ID: 1986401
[TBL] [Abstract][Full Text] [Related]
27. Concentration-dependent radiosensitizing effect of docetaxel in esophageal squamous cell carcinoma cells.
Miyanaga S; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2016 Feb; 48(2):517-24. PubMed ID: 26676807
[TBL] [Abstract][Full Text] [Related]
28. Activation of an ataxia telangiectasia mutation-dependent intra-S-phase checkpoint by anti-tumour drugs in HL-60 and human lymphoblastoid cells.
Sugimoto K; Tamayose K; Takagi M; Yamada K; Sasaki M; Mizutani S; Oshimi K
Br J Haematol; 2000 Sep; 110(4):819-25. PubMed ID: 11054063
[TBL] [Abstract][Full Text] [Related]
29. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.
Smith PJ; Souès S; Gottlieb T; Falk SJ; Watson JV; Osborne RJ; Bleehen NM
Br J Cancer; 1994 Nov; 70(5):914-21. PubMed ID: 7947097
[TBL] [Abstract][Full Text] [Related]
30. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
Zhang AL; Russell PJ; Knittel T; Milross C
Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
[TBL] [Abstract][Full Text] [Related]
31. 8-Aminoadenosine enhances radiation-induced cell death in human lung carcinoma A549 cells.
Meike S; Yamamori T; Yasui H; Eitaki M; Matsuda A; Inanami O
J Radiat Res; 2011; 52(4):456-63. PubMed ID: 21785234
[TBL] [Abstract][Full Text] [Related]
32. Interaction of ionizing radiation and ZRBA1, a mixed EGFR/DNA-targeting molecule.
Heravi M; Rachid Z; Goudarzi A; Schlisser A; Jean-Claude BJ; Radzioch D; Muanza TM
Anticancer Drugs; 2009 Sep; 20(8):659-67. PubMed ID: 19581798
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of radiation-induced apoptosis of human lymphoma U937 cells by sanazole.
Yu DY; Zhao QL; Wei ZL; Nomura T; Kashiwakura I; Kagiya TV; Kondo T
Apoptosis; 2009 May; 14(5):655-64. PubMed ID: 19259823
[TBL] [Abstract][Full Text] [Related]
34. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells.
Varshney R; Dwarakanath B; Jain V
Int J Radiat Biol; 2005 May; 81(5):397-408. PubMed ID: 16076755
[TBL] [Abstract][Full Text] [Related]
35. KPU-300, a Novel Benzophenone-Diketopiperazine-Type Anti-Microtubule Agent with a 2-Pyridyl Structure, Is a Potent Radiosensitizer That Synchronizes the Cell Cycle in Early M Phase.
Okuyama K; Kaida A; Hayashi Y; Hayashi Y; Harada K; Miura M
PLoS One; 2015; 10(12):e0145995. PubMed ID: 26716455
[TBL] [Abstract][Full Text] [Related]
36. SR 4233: a tumor specific radiosensitizer active in fractionated radiation regimes.
Brown JM; Lemmon MJ
Radiother Oncol; 1991; 20 Suppl 1():151-6. PubMed ID: 2020764
[TBL] [Abstract][Full Text] [Related]
37. Enterolactone: A novel radiosensitizer for human breast cancer cell lines through impaired DNA repair and increased apoptosis.
Bigdeli B; Goliaei B; Masoudi-Khoram N; Jooyan N; Nikoofar A; Rouhani M; Haghparast A; Mamashli F
Toxicol Appl Pharmacol; 2016 Dec; 313():180-194. PubMed ID: 27984132
[TBL] [Abstract][Full Text] [Related]
38. SMS 201-995 enhances S-phase block induced by 5-fluorouracil in a human colorectal cancer cell line.
Massari D; Trobonjac Z; Rukavina D; Radosević-Stasić B
Anticancer Drugs; 2005 Oct; 16(9):989-96. PubMed ID: 16162975
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and radiosensitizing effect of PR-350.
Hirokawa K; Nakajima T; Tsumura M; Nishita T; Yamada R; Onoyama Y
Radiat Med; 1997; 15(1):45-9. PubMed ID: 9134584
[TBL] [Abstract][Full Text] [Related]
40. The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer.
Miyake K; Shimada M; Nishioka M; Sugimoto K; Batmunkh E; Uto Y; Nagasawa H; Hori H
Cancer Lett; 2008 Dec; 272(2):325-35. PubMed ID: 18762366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
